Market Research Reports Cystic Fibrosis Patient Digital Landscape | Page 2

The Global Cystic Fibrosis Market is segmented based on the Treatment Method and Region. On the
basis of Treatment Method, the Global Cystic Fibrosis Market is classified into medication, devices,
and other treatments. The Medication segment commands the maximum share.
In terms of the geographic analysis, North America is leading the market with substantial market
revenue. Europe, on the other hand, is the fastest growing market. It has the similar structural
benefit and government support like that of North America which are driving the market ahead. The
Asia-Pacific market is showing significant progress. However, a reported case regarding the disease is
rare. China and Japan are countries where the disease is extremely rare.
Top Leading Key Players in Global Cystic Fibrosis Market: Vertex Pharmaceuticals, F. Hoffmann-La
Roche, AbbVie, Gilead Sciences, Novartis, Genentech, Pharmaxis, Chiesi Farmaceutici, Forest
Laboratories and others. New product launches and continuous technological innovations are the
key strategies adopted by the major players.
Current Business News:
Roche (May 31, 2019) – Roche and GE Healthcare launch NAVIFY Tumor Board with Medical Imaging
Capabilities to Enable More Personalised Treatment Decisions in Cancer Care –Roche announced
today the release of NAVIFY Tumor Board 2.0, the first collaboration product from our partnership
with GE Healthcare. Incorporating medical image viewing and storage capabilities with other patient
data, the product enables tumour boards - multi-disciplinary teams who determine treatment plans
for cancer patients - to have a more comprehensive view of each patient in one place.
Bringing together patient medical records from various systems for review by tumour boards can be
time-consuming and cumbersome. The integration of GE Healthcare’s medical image viewer into
NAVIFY Tumor Board 2.0 enables radiologists to upload their patient records to the same dashboard
where patient files from other disciplines in the cancer care team are stored. Having complete
patient diagnostic information in one location helps specialists use the limited time they have during
tumour boards to review all relevant files quickly and align on the best possible treatment plan for
each cancer patient.
“This new version of NAVIFY Tumor Board is the first product developed in partnership with GE
Healthcare and demonstrates our shared vision of accelerating personalised healthcare,” said
Michael Heuer, CEO Roche Diagnostics. “Our mutual focus is on delivering clinical decision support
solutions that enable healthcare professionals to make faster, more confident decisions, allowing
more personalized treatment based on truly integrated diagnostics.”
Region segment: This report is segmented into several key regions, with sales, revenue, market
share (%) and growth Rate (%) of Cystic Fibrosis in these regions, from 2013 to 2023 (forecast),
covering: North America, Europe, Asia Pacific, Middle East & Africa and South America
Purchase this report online with 50 Pages, List of Tables & Figures and in-depth Table of Contents
on “Global Cystic Fibrosis Market Report 2019” @ https://www.businessindustryreports.com/buy-
now/162996/single .
About us